Skip to main content

Table 1 Demographical and clinical characteristics of patients

From: Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Groups RRMS SPMS
N 35 50
Mean age (years)* 40.2 ± 1.2 52.2 ± 1.1
F (M) 20 (15) 34 (16)
IFN treated (untreated) 10 (25) 20 (30)
Mean EDSS* 2.2 ± 0.2 6.8 ± 0.1
Mean disease duration (years)* 6.8 ± 0.8 18.1 ± 1.4
  1. *p-value <0.05